pubmed-article:20304838 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0003507 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C1555029 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C1637379 | lld:lifeskim |
pubmed-article:20304838 | lifeskim:mentions | umls-concept:C0215147 | lld:lifeskim |
pubmed-article:20304838 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:20304838 | pubmed:dateCreated | 2010-8-16 | lld:pubmed |
pubmed-article:20304838 | pubmed:abstractText | Aortic stenosis (AS) is associated with significant morbidity and mortality. Recombinant apolipoprotein A-I Milano (rApoA-I(M)) induces atherosclerotic plaque regression. The aims of this study were to determine the effects of rApoA-I(M) on experimental aortic valve degeneration and its mechanisms of action. | lld:pubmed |
pubmed-article:20304838 | pubmed:language | eng | lld:pubmed |
pubmed-article:20304838 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20304838 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20304838 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20304838 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20304838 | pubmed:issn | 1522-9645 | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:GarciaMario... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:FusterValenti... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:BadimonJuan... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:CimminoGiovan... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:SpeidlWalter... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:GoldmanMartin... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:HutterRandolp... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:ElmariahSammy... | lld:pubmed |
pubmed-article:20304838 | pubmed:author | pubmed-author:IbanezBorjaB | lld:pubmed |
pubmed-article:20304838 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20304838 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:20304838 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20304838 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20304838 | pubmed:pagination | 2049-57 | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:meshHeading | pubmed-meshheading:20304838... | lld:pubmed |
pubmed-article:20304838 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20304838 | pubmed:articleTitle | Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. | lld:pubmed |
pubmed-article:20304838 | pubmed:affiliation | Atherothrombosis Research Unit, Mount Sinai School of Medicine New York, NY, USA. | lld:pubmed |
pubmed-article:20304838 | pubmed:publicationType | Journal Article | lld:pubmed |